Matthew Lynes

Dr. Matthew Lynes

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2021 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
AAAnthony R. Angueira
Anthony R. Angueira
ASAlexander P. Sakers
Alexander P. Sakers
CHCorey D. Holman
Corey D. Holman
LCLan Cheng
Lan Cheng
MAMichelangella N. Arbocco
Michelangella N. Arbocco
PSPatrick Seale
Patrick Seale

26 August 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
CWChih-Hao Wang
Chih-Hao Wang
MLMorten Lundh
Morten Lundh
AFAccalia Fu
Accalia Fu
RKRókus Kriszt
Rókus Kriszt
THTian Lian Huang
Tian Lian Huang
YTYu-Hua Tseng
Yu-Hua Tseng
Human white adipocytes engineered to express UCP1 activate endogenous BAT and protect against diet-induced obesity when transplanted into mice.

12 April 2021 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
FSFarnaz Shamsi
Farnaz Shamsi
MPMary Piper
Mary Piper
LHLi-Lun Ho
Li-Lun Ho
THTian Lian Huang
Tian Lian Huang
AGAnushka Gupta
Anushka Gupta
YTYu-Hua Tseng
Yu-Hua Tseng

10 February 2020 in PLOS Biology
Verified
Journal Article
Open access
PDF file
MSMari Sato
Mari Sato
TTTadataka Tsuji
Tadataka Tsuji
KYKunyan Yang
Kunyan Yang
XRXiaozhi Ren
Xiaozhi Ren
JDJonathan M Dreyfuss
Jonathan M Dreyfuss
YTYu-Hua Tseng
Yu-Hua Tseng
Opsin3 (Opn3) is a transmembrane heptahelical G protein–coupled receptor (GPCR) with the potential to produce a nonvisual photoreceptive effect. Interestingly, anatomical profiling of GPCRs reveals that Opn3 mRNA is highly expressed in adipose tissue. The photosensitive functions of Opn3 in mammals are poorly understood, and whether Opn3 has a role in fat is entirely unknown. In this study, we found that Opn3-knockout (Opn3-KO) mice were prone to diet-induced obesity and insulin resistance. At the cellular level, Opn3-KO brown adipocytes cultured in darkness had decreased glucose uptake and lower nutrient-induced mitochondrial respiration than wild-type (WT) cells. Light exposure promoted mitochondrial activity and glucose uptake in WT adipocytes but not in Opn3-KO cells. Brown adipocytes carrying a defective mutation in Opn3’s putative G protein–binding domain also exhibited a reduction in glucose uptake and mitochondrial respiration in darkness. Using RNA-sequencing, we identified several novel light-sensitive and Opn3-dependent molecular signatures in brown adipocytes. Importantly, direct exposure of brown adipose tissue (BAT) to light in living mice significantly enhanced thermogenic capacity of BAT, and this effect was diminished in Opn3-KO animals. These results uncover a previously unrecognized cell-autonomous, light-sensing mechanism in brown adipocytes via Opn3-GPCR signaling that can regulate fuel metabolism and mitochondrial respiration. Our work also provides a molecular basis for developing light-based treatments for obesity and its related metabolic disorders.

8 July 2022 in Circulation Research
Verified
Journal Article
Closed access
PDF file
KPKyoungmin Park
Kyoungmin Park
QLQian Li
Qian Li
MLMatthew Lynes
Matthew Lynes
HYHisashi Yokomizo
Hisashi Yokomizo
EMErnesto Maddaloni
Ernesto Maddaloni
GKGeorge L King
George L King
Background: Insulin resistance (IR) can increase atherosclerotic and cardiovascular risk by inducing endothelial dysfunction, decreasing nitric oxide (NO) production, and accelerating arterial inflammation. The aim is to determine the mechanism by which insulin action and NO production in endothelial cells can improve systemic bioenergetics and decrease atherosclerosis via differentiation of perivascular progenitor cells (PPCs) into brown adipocytes (BAT). Methods: Studies used various endothelial transgenic and deletion mutant ApoE −/− mice of insulin receptors, eNOS (endothelial NO synthase) and ETBR (endothelin receptor type B) receptors for assessments of atherosclerosis. Cells were isolated from perivascular fat and micro-vessels for studies on differentiation and signaling mechanisms in responses to NO, insulin, and lipokines from BAT. Results: Enhancing insulin’s actions on endothelial cells and NO production in ECIRS1 transgenic mice reduced body weight and increased systemic energy expenditure and BAT mass and activity by inducing differentiation of PPCs into beige/BAT even with high-fat diet. However, positive changes in bioenergetics, BAT differentiation from PPCs and weight loss were inhibited by N(gamma)-nitro-L-arginine methyl ester ( L -NAME), an inhibitor of eNOS, in ECIRS1 mice and eNOSKO mice. The mechanism mediating NO’s action on PPC differentiation into BAT was identified as the activation of solubilized guanylate cyclase/PKGIα (cGMP protein-dependent kinase Iα)/GSK3β (glycogen synthase kinase 3β) pathways. Plasma lipidomics from ECIRS1 mice with NO-induced increased BAT mass revealed elevated 12,13-diHOME production. Infusion of 12,13-diHOME improved endothelial dysfunction and decreased atherosclerosis, whereas its reduction had opposite effects in ApoE − /− mice. Conclusions: Activation of eNOS and endothelial cells by insulin enhanced the differentiation of PPC to BAT and its lipokines and improved systemic bioenergetics and atherosclerosis, suggesting that endothelial dysfunction is a major contributor of energy disequilibrium in obesity.

1 January 2021 in Cell Reports
Verified
Journal Article
Open access
CSChristian Schlein
Christian Schlein
AFAlexander Fischer
Alexander Fischer
FSFrederike Sass
Frederike Sass
AWAnna Worthmann
Anna Worthmann
KTKlaus Tödter
Klaus Tödter
LSLudger Scheja
Ludger Scheja
Thermoneutral conditions typical for standard human living environments result in brown adipose tissue (BAT) involution, characterized by decreased mitochondrial mass and increased lipid deposition. Low BAT activity is associated with poor metabolic health, and BAT reactivation may confer therapeutic potential. However, the molecular drivers of this BAT adaptive process in response to thermoneutrality remain enigmatic. Using metabolic and lipidomic approaches, we show that endogenous fatty acid synthesis, regulated by carbohydrate-response element-binding protein (ChREBP), is the central regulator of BAT involution. By transcriptional control of lipogenesis-related enzymes, ChREBP determines the abundance and composition of both storage and membrane lipids known to regulate organelle turnover and function. Notably, ChREBP deficiency and pharmacological inhibition of lipogenesis during thermoneutral adaptation preserved mitochondrial mass and thermogenic capacity of BAT independently of mitochondrial biogenesis. In conclusion, we establish lipogenesis as a potential therapeutic target to prevent loss of BAT thermogenic capacity as seen in adult humans.